Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Tesla and GM dominate the week's agenda. GM reports Tuesday 20 October. Tesla follows on Wednesday. Both carry short interest below 2.5% of free float, suggesting bears are not betting against either name into the print. ORTEX alt data using German car registrations, which leads GM revenue by 15 days with a strong fit, is running 133% above the same quarter last year. For Tesla, the same dataset leads revenue by 43 days and is running 269% above prior-year levels. Both readings point upward heading into this week's results. Options markets are active on both names.
Away from autos, Chewy has drawn the sharpest short interest move among large-caps this week. Short interest jumped to 91.2% of free float, up from 65.9% seven days ago. That 25-point surge stands out in ORTEX data. The pet retailer has a $4.7 billion market cap. Bears appear unconvinced by any recovery story.
Analysts backed cybersecurity today. Fortinet and Palo Alto Networks both received upgrades. Utilities went the other way. The Southern Company and Ameren were both downgraded. Elevated rate expectations continue to weigh on defensive names. Eli Lilly is in focus after positive Phase 3 data on Omvoh for children with ulcerative colitis.
Today is the MSCI World rank date. Fabrinet's exit probability jumped to 90% overnight, sitting 15% below the threshold. That implies $779 million of potential forced selling from MSCI World trackers on the 30 November trade date. In Italy, CVC's agreed tender offer for Recordati carries 82% completion odds. If it closes, $220 million of FTSE MIB selling would follow.
Renault reports Thursday. Its alt-data signals are mixed: Austrian car registrations point to 6% growth, while Dutch registrations are running 19% below last year.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.